BERKLEY W R CORP - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 42 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BERKLEY W R CORP ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q4 2022$198,465
+1.8%
19,6500.0%0.01%
+22.2%
Q3 2022$195,000
+1.6%
19,6500.0%0.01%
-10.0%
Q2 2022$192,000
+0.5%
19,6500.0%0.01%0.0%
Q1 2022$191,000
+0.5%
19,6500.0%0.01%0.0%
Q4 2021$190,000
-0.5%
19,6500.0%0.01%
-23.1%
Q3 2021$191,000
+0.5%
19,6500.0%0.01%
-31.6%
Q2 2021$190,00019,6500.02%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Tyrus Capital S.A.M. 400,000$4,040,0008.80%
GRITSTONE ASSET MANAGEMENT LLC 55,952$565,1150.72%
PERISCOPE CAPITAL INC. 776,797$7,845,6500.34%
GLAZER CAPITAL, LLC 1,254,733$12,6730.33%
MMCAP International Inc. SPC 250,000$2,525,0000.26%
GABELLI & Co INVESTMENT ADVISERS, INC. 65,689$663,4590.14%
First Trust Capital Management L.P. 256,426$2,589,9030.14%
PICTON MAHONEY ASSET MANAGEMENT 274,995$2,7780.13%
KIM, LLC 200,000$2,0200.11%
Exos TFP Holdings LLC 35,970$363,2970.10%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders